Glucagon protects against impaired NMDA-mediated cerebrovasodilation and cerebral autoregulation during hypotension after brain injury by activating cAMP protein kinase A and inhibiting upregulation of tPA.

Outcome of traumatic brain injury (TBI) is impaired by hyperglycemia, hypotension, and glutamate, and improved by insulin. Insulin reduces glutamate concentration, making it uncertain whether its beneficial effect accrues from euglycemia. Glucagon decreases CNS glutamate, lessens neuronal cell injury, and improves neurological scores in mice after TBI. In vitro, glucagon limits NMDA-mediated excitotoxicity by increasing cAMP and protein kinase A (PKA). NMDA receptor activation couples cerebral blood flow (CBF) to metabolism. Dilation induced by NMDA is impaired after fluid percussion brain injury (FPI) due to upregulation of endogenous tPA, which further disturbs cerebral autoregulation during hypotension after fluid percussion injury (FPI). We hypothesized that glucagon prevents impaired NMDA receptor-mediated dilation after FPI by upregulating cAMP, which decreases release of tPA. NMDA-induced pial artery dilation (PAD) was reversed to vasoconstriction after FPI. Glucagon 30 min before or 30 min after FPI blocked NMDA-mediated vasoconstriction and restored the response to vasodilation. PAD during hypotension was blunted after FPI, but protected by glucagon. Glucagon prevented FPI-induced reductions in CSF cAMP, yielding a net increase in cAMP, and blocked FPI-induced elevation of CSF tPA. Co-administration of the PKA antagonist Rp 8Br cAMPs prevented glucagon-mediated preservation of NMDA-mediated dilation after FPI. The pKA agonist Sp 8Br cAMPs prevented impairment of NMDA-induced dilation. These data indicate that glucagon protects against impaired cerebrovasodilation by upregulating cAMP, which decreases release of tPA, suggesting that it may provide neuroprotection when given after TBI, or prior to certain neurosurgical or cardiac interventions in which the incidence of perioperative ischemia is high.

[1]  W. Armstead,et al.  tPA contributes to impaired NMDA cerebrovasodilation after traumatic brain injury through activation of JNK MAPK , 2011, Neurological research.

[2]  J. Orme,et al.  Clinical Impact of Early Hyperglycemia During Acute Phase of Traumatic Brain Injury , 2009, Neurocritical care.

[3]  S. Stein,et al.  uPA Modulates the Age-Dependent Effect of Brain Injury on Cerebral Hemodynamics through LRP and ERK MAPK , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[4]  K. Inaba,et al.  Persistent Hyperglycemia in Severe Traumatic Brain Injury: An Independent Predictor of Outcome , 2009, The American surgeon.

[5]  F. Bilotta,et al.  Intensive Insulin Therapy After Severe Traumatic Brain Injury: A Randomized Clinical Trial , 2008, Neurocritical care.

[6]  C. Iadecola,et al.  Key role of tissue plasminogen activator in neurovascular coupling , 2008, Proceedings of the National Academy of Sciences.

[7]  H. Bramlett,et al.  Modulation of the cAMP signaling pathway after traumatic brain injury , 2007, Experimental Neurology.

[8]  W. Armstead,et al.  Plasminogen activators contribute to age-dependent impairment of NMDA cerebrovasodilation after brain injury. , 2005, Brain research. Developmental brain research.

[9]  Sidney Strickland,et al.  Ethanol-withdrawal seizures are controlled by tissue plasminogen activator via modulation of NR2B-containing NMDA receptors. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[10]  D. Drucker,et al.  Extrahypothalamic expression of the glucagon-like peptide-2 receptor is coupled to reduction of glutamate-induced cell death in cultured hippocampal cells. , 2004, Endocrinology.

[11]  V. Teichberg,et al.  Blood‐mediated scavenging of cerebrospinal fluid glutamate , 2003, Journal of neurochemistry.

[12]  W. Armstead.  Age dependent NMDA contribution to impaired hypotensive cerebral hemodynamics following brain injury. , 2002, Brain research. Developmental brain research.

[13]  Cheng Liren,et al.  Excitatory Amino Acids in Cerebrospinal Fluid of Patients with Acute Head Injuries , 2001 .

[14]  S. Lipton,et al.  Tissue plasminogen activator (tPA) increase neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice , 1998, Nature Medicine.

[15]  W. Armstead.  Role of impaired cAMP and calcium-sensitive K+ channel function in altered cerebral hemodynamics following brain injury , 1997, Brain Research.

[16]  Sidney Strickland,et al.  Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator , 1995, Nature.

[17]  W. Armstead,et al.  Effects of ischemia on brain blood flow and oxygen consumption of newborn pigs. , 1989, The American journal of physiology.

[18]  R. Green,et al.  Effects of Indomethacin upon Cerebral Hemodynamics of Newborn Pigs , 1985, Pediatric Research.

[19]  W. Oh,et al.  The effect of carotid artery ligation on brain blood flow in newborn piglets , 1983, Brain Research.

[20]  J. Povlishock,et al.  Functional, Morphological, and Metabolic Abnormalities of the Cerebral Microcirculation after Concussive Brain Injury in Cats , 1980, Circulation research.

[21]  E. N. Bergman,et al.  Effects of glucagon and insulin on net hepatic metabolism of glucose precursors in sheep. , 1975, The American journal of physiology.

[22]  G. Goelman,et al.  Neuroprotection by glucagon: role of gluconeogenesis. , 2011, Journal of neurosurgery.

[23]  Alain Buisson,et al.  The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling , 2001, Nature Medicine.

[24]  D. Heistad,et al.  Regulation of the cerebral circulation: role of endothelium and potassium channels. , 1998, Physiological reviews.